À¯ÁØȯ
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ¿°Áõ¼ºÀåÁúȯ, ´ëÀå¾Ï, Ä¡·á³»½Ã°æ
Á÷
ˤ
: ºÎ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
23
ÇØ¿Ü
Fibrostenotic strictures in Crohn¡¯s disease
22
ÇØ¿Ü
Umbilical cord placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A
21
ÇØ¿Ü
Periodontitis is associated with an increased risk for proximal colorectal neoplasms
20
ÇØ¿Ü
Intestinal enteroids organoids - A novel platform for drug discovery in inflammatory bowel diseases.
19
ÇØ¿Ü
Organoid-based epithelial to mesenchymal transition model_from an intestinal fibrosis perspective
18
ÇØ¿Ü
Anti-fibrogenic effect of PPAR-g agonists in human intestinal myofibroblasts
17
ÇØ¿Ü
Overview of gastrointestinal cancer prevention in Asia
16
ÇØ¿Ü
Dietary prevention of Helicobacter pylori-associated gastric cancer with Kimchi
15
ÇØ¿Ü
Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction A randomized controlled trial
14
ÇØ¿Ü
Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases
1
2
3
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729